| COVID-19 |
1 |
1 |
| Post-Acute Sequelae of SARS-CoV-2 Infection |
0 |
1 |
| Otolaryngology |
0 |
0.48 |
| Pain Management |
0 |
0.41 |
| Abdominal Pain |
0 |
0.34 |
| Chest Pain |
0 |
0.34 |
| Angina Pectoris |
0 |
0.32 |
| Pain |
0 |
0.29 |
| Polymerase Chain Reaction |
0 |
0.29 |
| Acute Pain |
0 |
0.26 |
| Acute Respiratory Distress Syndrome |
0 |
0.23 |
| Severe Acute Respiratory Syndrome |
0 |
0.22 |
| Anxiety Disorder |
0 |
0.21 |
| Cancer Pain |
0 |
0.21 |
| Abdomen |
0 |
0.15 |
| Anxiety |
0 |
0.15 |
| Chronic Disease |
0 |
0.15 |
| Dorsum |
0 |
0.15 |
| Fatigue |
0 |
0.15 |
| Nausea |
0 |
0.15 |
| Thorax |
0 |
0.15 |
| Vertigo |
0 |
0.15 |
| Chronic Kidney Disease |
0 |
0.14 |
| Renal Failure |
0 |
0.14 |
| Type 1 Diabetes Mellitus |
0 |
0.12 |
| Hemoglobin A1c |
0 |
0.1 |
| Renal Disease |
0 |
0.1 |
| HIV Infection |
0 |
0.08 |
| Medical Life |
0 |
0.08 |
| Obesity |
0 |
0.08 |
| Sleep Disorders |
0 |
0.08 |
| Allergy |
0 |
0.07 |
| Blood |
0 |
0.07 |
| Cancer |
0 |
0.07 |
| Clinical Guidelines |
0 |
0.07 |
| Diabetic Ketoacidosis |
0 |
0.07 |
| Dizziness |
0 |
0.07 |
| Dyspnea |
0 |
0.07 |
| Fever |
0 |
0.07 |
| Fluid and Electrolyte Disorders |
0 |
0.07 |
| Hemoglobin |
0 |
0.07 |
| Impairment |
0 |
0.07 |
| Insomnia |
0 |
0.07 |
| Intensive Care Unit |
0 |
0.07 |
| Kidney |
0 |
0.07 |
| Match |
0 |
0.07 |
| Medicaid |
0 |
0.07 |
| Nerve |
0 |
0.07 |
| Opportunistic Infection |
0 |
0.07 |
| Pancreas |
0 |
0.07 |
| Pandemic |
0 |
0.07 |
| Vitiligo |
0 |
0.07 |